Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Dow
Mallinckrodt
Medtronic
Johnson and Johnson

Last Updated: October 18, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR PITOCIN

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Pitocin

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00308711 Safety/Efficacy Study Comparing the Misoprostol Vaginal Insert to Cervidil for Cervical Ripening and Induction of Labor Completed Ferring Pharmaceuticals Phase 3 2006-04-01 The purpose of this study is to determine whether the misoprostol vaginal insert (50 mcg and 100 mcg) can safely and effectively speed time to vaginal delivery compared to Cervidil (R) in women who need to have cervical ripneing and induction of labor.
NCT00684606 Transcervical Foley Catheter With or Without Oxytocin for Induction of Labor Unknown status Sheba Medical Center N/A 2008-05-01 The purpose of the present study is to evaluate the possible benefit of concurrent IV Oxytocin infusion with trans cervical Foley catheter for pre-induction cervical ripening.
NCT00784797 Misopristol Versus Pitocin for Second Trimester Abortion Completed Hadassah Medical Organization Phase 4 2009-01-01 Second trimester abortion can be done surgically or medically. Medical abortion with mifepristone and misopristol is one of the common protocol, but misopristol have high rate side effect. The investigators recent study proved the efficacy of pitocin after mifepristone in second trimester abortion with minimal side effects. Working hypothesis and aims: To compare misopristol and pitocin after mifepristone preparation in second trimester in seccess rate, interval to abortion, side effects and patient satisfaction.
NCT00891150 Oxytocin to Decrease Blood Loss During Cesarean Section Completed American University of Beirut Medical Center N/A 2012-07-01 The goal of this study is to determine the best dose of a drug called oxytocin, that is usually used to stop bleeding during a delivery, when used during a cesarean delivery. It will be administered during cesarean section in order to decrease the amount blood loss. The investigators are proposing to have 3 groups of subjects each given a different safe dose of oxytocin and then to assess the effectiveness of each regimens on the amount blood lost during cesarean sections.This will let use know which is the best lowest dose needed.
NCT00984347 Breast Stimulation Versus Pitocin for Induction of Labor Unknown status Hadassah Medical Organization N/A 2009-11-01 The purpose of the trial is to compare nipple stimulation with a breast pump to pitocin for induction of labor in term pregnancies.
NCT01011465 The Biology of Resilience Completed Brigham and Women's Hospital N/A 2009-02-01 Positive social relationships have consistently been associated with better health, although the neurobiological underpinnings of these observed effects remain largely unknown. The overall goal of the proposed work is to explore novel biological pathways that may explain how social relationships influence health. Recent theorizing suggests that the oxytocin system may underlie some of the observed beneficial effects. Four hypotheses will be examined: 1. Oxytocin ameliorates the deleterious neuroendocrine, cardiovascular, and subjective effects of stress. 2. Oxytocin and social support have similar and additive stress-buffering effects. 3. Effects of oxytocin are evident among younger and older adults. 4. Effects of oxytocin are stronger in women vs men.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Pitocin

Condition Name

Condition Name for Pitocin
Intervention Trials
Postpartum Hemorrhage 6
Pregnancy 4
Induction of Labor 3
Chronic Pain 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Pitocin
Intervention Trials
Hemorrhage 10
Postpartum Hemorrhage 7
Disease 2
Chronic Pain 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Pitocin

Trials by Country

Trials by Country for Pitocin
Location Trials
United States 43
Canada 8
Israel 4
Uganda 1
Lebanon 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Pitocin
Location Trials
California 5
South Carolina 4
Florida 3
Arizona 3
North Carolina 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Pitocin

Clinical Trial Phase

Clinical Trial Phase for Pitocin
Clinical Trial Phase Trials
Phase 4 10
Phase 3 4
Phase 2 4
[disabled in preview] 22
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Pitocin
Clinical Trial Phase Trials
Not yet recruiting 12
Recruiting 10
Completed 10
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Pitocin

Sponsor Name

Sponsor Name for Pitocin
Sponsor Trials
Medical University of South Carolina 5
Samuel Lunenfeld Research Institute, Mount Sinai Hospital 5
Wake Forest University Health Sciences 3
[disabled in preview] 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Pitocin
Sponsor Trials
Other 40
Industry 2
NIH 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Medtronic
Dow
Baxter
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.